List of Gene Therapy Companies in Utah - 3

Noorda-COM Pre-Accreditation Status Commission on Osteopathic College Accreditation (COCA) predoc@osteopathic.org Noorda-COM is a private institution situated at the edge of the East Bay Golf Course in Provo, Utah. Our mission at Noorda-COM is to empower our students with essential personal and professional skills needed to be competent, confident, and compassionate osteopathic physicians who are dedicated to meeting the healthcare challenges of the communities in which they serve. Our values align with instilling and fostering cultural awareness and ethical leadership, embracing diversity, and inspiring a servant's heart towards caring for the poor and needy. Noorda-COM offers osteopathic programs endorsed by local universities, Brigham Young and Utah Valley. Over the course of our program, students will expand on their medical experiences through simulation, clinical rotation, clerkship, and research projects. Our local healthcare providers are willingly partnered with us to complete this clinical portion of a medical education. Noorda-COM curriculum utilizes a blended classroom structure. No large classrooms, no regularly scheduled classes. Students will make their own schedule to meet in groups to complete modules and are assessed based on their progress. Module content is continuously being improved, since our staff is able monitor which lessons are effective with students and lessons that are not. Our campus is designed with the intention to create a stress-free environment. In addition to the incredible mountain-range view, our campus will have other attractive amenities including comfortable study areas for single person or group use, student and faculty lounges, fitness and recreation areas including access to the golf course and will be adjacent to campus housing.

Thunder Biotech, Inc. is an immune-oncology company developing patented MOTO-CAR™ technology - genetically engineered CAR macrophages - that help cancer patients' immune cells recognize and attack solid tumors. Traditional cancer treatments— like surgery, radiation, and chemotherapy—are often ineffective, invasive, and difficult to tolerate. Thunder Biotech is designing MOTO-CAR™s to be a more effective and humane therapy. Thunder Biotech's MOTO-CAR™s re-educate Tumor Associated Macrophages and restore their M1 ability to recognize and eliminate tumor cells. In addition, MOTO-CAR™s are armed with tumor specific receptors that directly adhere to the tumor cell surface allowing them to initiate tumor cell destruction and recruit the natural T cell response engaging them to eliminate the tumor. This T cell response will then provide the body with a memory response preventing tumor recurrence.

TikkunLev Therapeutics is on a mission to revolutionize the treatment of heart failure by targeting the underlying biology of failing heart muscle. Founded on the pioneering research of Professor Robin Shaw M.D., Ph.D., our lead program, TLT-101, is a precision therapy that targets the underlying protein trafficking defects in heart failure. Extensive preclinical data demonstrate an unprecedented efficacy and safety profile with our therapeutic approach. TLT-101 is in IND-enabling development for non-ischemic dilated cardiomyopathy (DCM), a severe and progressive disease that is a leading cause of heart failure. With cardiovascular disease remaining the leading global cause of death and 1 in 4 people expected to develop heart failure, our innovative approach aims to repair the heart and transform lives.